The US Food and Drug Administration has said that it hopes to open an office in China in order to safeguard imports to the US.


The move, an FDA representative told just-food today (17 April), marks a departure from the strategy of inspecting imports as they enter the US.


“The safety of imports from China has become an important issue. We have had a lot of health scares arising from unsafe products coming into the country. What we want to do is go out and prevent these problems before they arise,” the FDA official said.


The idea behind the move is to increase co-operation between Chinese and US regulators and companies, the FDA added.


“We would start with the one office, but there is obviously scope to expand operations,” the FDA told just-food.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It is believed that the FDA hopes to expand the project to include other countries and regions, such as India and Latin America.


The FDA is still awaiting approval from Beijing.